CHLORAPREP (chlorhexidine gluconate, isopropyl alcohol) - Antiseptic

Opinions on drugs - Posted on Sep 18 2024

Reason for request

Indication extension

Summary of opinion

Favourable opinion for reimbursement for disinfection of the skin prior to invasive medical procedures.

No clinical added value of the new form of CHLORAPREP 20 mg/ml + 0.70 ml/ml (chlorhexidine gluconate, isopropyl alcohol) pre-saturated swabstick compared to the forms with 1 ml, 1.5 ml and 3 ml ampoules inserted into a plastic applicator fitted with a sponge already listed.

Clinical Benefit

Substantial

The Committee deems that the clinical benefit of CIBINQO 50 mg, 100 mg and 200 mg (abrocitinib) film-coated tablets is substantial in the MA indication in adolescents 12 years and older.